| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $281K | +103.2% |
| SG&A Expense | $1.5M | +7.9% |
| Operating Income | -$1.8M | -16.7% |
| Pre-tax Income | -$1.8M | -16.7% |
| Net Income | -$1.8M | -16.7% |
| EPS (Basic) | -$0.12 | +7.7% |
| EPS (Diluted) | -$0.12 | +7.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $49K | -2.0% |
| Total Assets | $1.5M | +2947.0% |
| Current Liabilities | $5.0M | +47.2% |
| Total Liabilities | $5.0M | +47.2% |
| Stockholders' Equity | -$3.4M | -2.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$850K | -28.1% |
| Financing Cash Flow | $859K | +32.7% |